期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 130, 期 2, 页码 117-122出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2016.01.006
关键词
Oxaliplatin; Voltage-dependent calcium channel alpha(2)delta-1 subunit; Spinal cord; Pregabalin; Acute cold hypersensitivity
Oxaliplatin is a chemotherapeutic agent that is effective against various types of cancer including colorectal cancer. Acute cold hyperalgesia is a serious side effect of oxaliplatin treatment. Although the therapeutic drug pregabalin is beneficial for preventing peripheral neuropathic pain by targeting the voltage-dependent calcium channel alpha(2)delta-1 (Ca-v alpha(2)delta-1) subunit, the effect of oxaliplatin-induced acute cold hypersensitivity is uncertain. To analyze the contribution of the Ca-v alpha(2)delta-1 subunit to the development of oxaliplatin-induced acute cold hypersensitivity, Ca-v alpha(2)delta-1 subunit expression in the rat spinal cord was analyzed after oxaliplatin treatment. Behavioral assessment using the acetone spray test showed that 6 mg/kg oxaliplatin-induced cold hypersensitivity 2 and 4 days later. Oxaliplatin-induced acute cold hypersensitivity 4 days after treatment was significantly inhibited by pregabalin (50 mg/kg, p.o.). Oxaliplatin (6 mg/kg, i.p.) treatment increased the expression level of Ca-v alpha(2)delta-1 subunit mRNA and protein in the spinal cord 2 and 4 days after treatment. Immunohistochemistry showed that oxaliplatin increased Ca-v alpha(2)delta-1 subunit protein expression in superficial layers of the spinal dorsal horn 2 and 4 days after treatment. These results suggest that oxaliplatin treatment increases Ca-v alpha(2)delta-1 subunit expression in the superficial layers of the spinal cord and may contribute to functional peripheral acute cold hypersensitivity. (C) 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据